Posted by Michael Wonder on 11 Jan 2023
First and only rescue medication approved in the US for as needed use to reduce risk of asthma exacerbations
11 January 2023 - Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the US for the as needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.
The approval by the FDA was based on results from the MANDALA and DENALI Phase 3 trials.
